 |
Botulax, Nabota, Rentox
Botulinum toxin type A is widely used in aesthetic medicine to temporarily reduce the muscle activity responsible for dynamic facial wrinkles. By inhibiting acetylcholine release at the neuromuscular junction, botulinum toxin decreases excessive muscle contraction and allows the overlying skin to appear smoother.
For clinics and aesthetic practitioners, choosing an appropriate botulinum toxin product involves more than comparing vial sizes. Treatment area, muscle activity, dose, injection technique, product characteristics, and individual patient response can all influence the treatment outcome and duration.
Dermax supplies a range of Botulinum Toxin Type A products, including Sotorior®, Botulax®, Nabota®, Re N Tox®, and Toxara™ with 100U and 200U options available for selected products.
Suitable for professional aesthetic clinics, practitioners, distributors, and qualified buyers.
Botulinum toxin type A works at the neuromuscular junction, where motor nerve endings communicate with muscles.
Botulinum toxin injection → reduced acetylcholine release → reduced targeted muscle activity → less repetitive skin folding → smoother appearance of dynamic wrinkles
The effect is temporary because nerve terminals gradually recover and establish functional connections again. For this reason, botulinum toxin treatment generally requires periodic maintenance.
Botulinum toxin is particularly relevant to dynamic wrinkles, which become more visible when specific facial muscles contract.
Treatment areas should be selected according to facial anatomy, muscle activity, wrinkle pattern, and the practitioner's clinical assessment rather than simply following a fixed injection pattern.
Horizontal forehead lines are commonly associated with repeated contraction of the frontalis muscle, particularly during eyebrow elevation and facial expression.
Careful reduction of excessive frontalis activity can soften the appearance of horizontal lines while maintaining an appropriate degree of eyebrow movement.
Because the frontalis contributes to eyebrow elevation, treatment requires anatomical precision. Excessive reduction of muscle activity can affect eyebrow position and expression.
Frown lines, also called glabellar lines, appear vertically or diagonally between the eyebrows and become more pronounced during frowning.
They are primarily associated with activity from muscles including the corrugator supercilii and procerus.
Reducing excessive contraction in this region can soften the appearance of glabellar lines and create a more relaxed appearance.
Crow's feet are fine lines extending outward from the lateral corners of the eyes.
They are associated with repeated contraction of the orbicularis oculi muscle, particularly during smiling and squinting.
When appropriately treated, reducing excessive activity of this muscle can soften lateral canthal lines while maintaining natural facial expression.
Depending on the patient's anatomy and treatment objectives, botulinum toxin may also be considered for other expression-related lines, including certain nasal wrinkles and selected perioral or lower-face muscle activity.
These areas require particularly careful anatomical assessment because small changes in muscle activity can influence facial expression, oral function, or symmetry.
Nabota and Botulax are both Botulinum Toxin Type A products used in aesthetic medicine. However, it is not clinically appropriate to assume that one brand will always last longer than the other.
| Product | Common vial options | Key consideration |
|---|---|---|
| Botulax® | 100U / 200U | Available in different strengths for professional applications |
| Nabota® | 100U / 200U | Botulinum Toxin Type A option for aesthetic practice |
| Sotorior® | 100U / 200U | Dermax's own Botulinum Toxin Type A brand |
| Re N Tox® | 100U / 200U | Another Botulinum Toxin Type A option |
| Toxara™ | 100U | Professional aesthetic application |
Important: Product characteristics and regulatory availability may differ between markets. Clinics and distributors should verify the applicable local requirements before purchasing or using any botulinum toxin product.
Dermax supplies a selection of Botulinum Toxin Type A products for professional aesthetic applications.
Our portfolio includes both Dermax's own brands and established Botulinum Toxin Type A products, allowing clinics, distributors, and professional buyers to select products according to their market requirements and treatment protocols.
Sotorior® is Dermax's own Botulinum Toxin Type A brand, available in 100U and 200U presentations.
It is positioned for professional aesthetic applications where practitioners require a Botulinum Toxin Type A option with different vial strengths.
Botulax® is available in 100U and 200U options and is commonly considered by professional aesthetic clinics seeking different vial strengths for treatment planning.
Nabota® is available in 100U and 200U presentations for professional aesthetic applications.
Re N Tox® is another Botulinum Toxin Type A option available through Dermax, with 100U and 200U presentations.
Hutox® is also included in Dermax's Botulinum Toxin Type A portfolio for professional buyers.
Dermax provides Botulinum Toxin Type A products for international professional buyers, including aesthetic clinics, medical practitioners, distributors, and qualified purchasers.
Our portfolio includes Sotorior®, Botulax®, Nabota®, Re N Tox®, and Hutox®, with selected products available in 100U and 200U presentations.
Rather than offering only one product, Dermax provides multiple Botulinum Toxin Type A options so professional buyers can select products according to their market and treatment requirements.
Competitive pricing does not mean compromising product selection or professional supply standards.
Multiple Botulinum Toxin Type A options
Selected 100U and 200U presentations
Professional and bulk purchasing support
International supply
Product consultation for clinics and distributors
Competitive pricing for professional buyers
Looking for Botulinum Toxin Type A for your clinic or distribution business? Contact Dermax for product availability, specifications, and purchasing information.
Choose from Dermax's selection of Botulinum Toxin Type A products, including Sotorior®, Botulax®, Nabota®, Re N Tox®, and Toxara™.
Contact Dermax for product details, availability, and professional purchasing support.
Botulinum toxin injections are primarily used to temporarily reduce excessive muscle activity associated with dynamic facial wrinkles, including forehead lines, glabellar lines, and crow's feet.
Botulinum toxin temporarily inhibits acetylcholine release at the neuromuscular junction. This reduces contraction of the targeted muscle and decreases repeated folding of the overlying skin.
The duration varies according to treatment area, dose, muscle activity, injection technique, and individual response. Effects are temporary and maintenance treatment may be required.
Neither product should be assumed to have a universally longer duration. Treatment duration depends on multiple clinical factors, including dose, treatment area, muscle activity, technique, and individual response.
The main difference is the amount of botulinum toxin contained in the vial. The appropriate presentation depends on the product, treatment protocol, clinical application, and practitioner requirements.
Clinics, distributors, and qualified professional buyers can contact Dermax to inquire about available Botulinum Toxin Type A products, vial strengths, specifications, and purchasing options.
